Evaluation of Gastrointestinal Life Quality and Food Consumption and Choices in Recovered Covid-19 Patients

Dilşat Baş; Şengül Sangu Talak; Nur Ecem Baydı Ozman; Deniz Nadide Kitay; Hazal Çatırtan; Ayşe Sena Binöz; Nilay Öngen; Efe Onganer; Murat Baş

doi:10.31067/acusaglik.1086369

EN

Evaluation of Gastrointestinal Life Quality and Food Consumption and Choices in Recovered Covid-19 Patients

Abstract

ABSTRACT BACKGROUND/OBJECTIVES: To get information about how gastrointestinal symptoms affected their nutrition and food preferences of the patients after recovering from the coronavirus disease 2019 (COVID-19) . SUBJECTS/METHODS: The study was conducted with the patients between the age of 18-65 who recovered and discharged from between 15th May 2020-15th June 2020. 594 of those patints whose e-mail adress was recorded in the system was sent the questionnaire via e-mail. 76 of those patients replied the e-mail. The questionnaire contains demographical information, supplement use, food preferences, a gastrointestinal quality of life questionnaire (GIQLI) formed of 36 questions encompassing 4 area and 3 of them is about life quality: Physical function, emotional function, social function and gastrointestinal symptoms. RESULTS: Weight loss after discharge was found significant for both genders (p<0.001). The hospitalization day and the loss of appetite and smell was significantly higher in male participants (p<0.001, p<0.05 respectively). GIQLI scores of male participants were significantly higher (p<0.05). Vitamin C, probiotics and multivitamins & minerals supplements were popular among recovered COVID-19 cases. After the COVID-19 infection, an increase in patients' fresh vegetables-fruits, nuts, yoghurt, herbal tea and water consumption was detected. Gender, the regular probiotic use before and after COVID-19 infection were significantly related to total score of GIQLI (p <0.001). CONCLUSION: Gastrointestinal system (GIS) and appetite is affected by COVID-19 infection. Healthy and symptomatic nutrition is important for treatment. The guidelines about nutrition and probiotic use should be reevaluated.

Keywords

References

1. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster. Lancet 2020; 395:514–523.
2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708–1720.
3. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–273.
4. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; 158(6):1831–1833.
5. Wu Y, Guo C, Tang L,et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434–435.
6. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’’ in COVID-19.’ J Infect 2020; 80: 607–613.
7. Kim S, Su K. Using psychoneuroimmunity against COVID-19. Brain , Behav , Immun 2020; 87: 4-5.
8. Childs, C. E., Calder, P. C., & Miles, E. A. Diet and immune function. Nutrients 2019; 11,1933:1–9

9. Baş M.Yaşam Dediğin 9 Metre.İstanbul: Destek Yayınları; 2019.
10. WHO (2020) Nutrition advice for adults during the COVID-19 outbreak. http://www.emro.who.int/nutrition/nutrition-infocus/nutrition-advice-for-adults-during-the-covid-19-outbreak.html
11. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument. Br J Soc 1995; 82: 216–222
12. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. Who. 2021. p. 1–5. Available from: https://covid19.who.int/
13. Wang D, Hu B, Hu C, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc 2020; 323(11):1061–1069.
14. Lee N, Yuen KY, Sung JJY. Enteric involvement of severe acute respiratory syndrome. Gastroenterology 2003; 125: 1011–1017.
15. Huang C, Wang Y, Li X,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
16. Wang X, Zhou Y, Jiang N, Zhou Q, Ma WL. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int J Infect Dis 2020; 95: 433–435.
17. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China. Am J Gastroenterol (2020) 115:766–773.
18. Jayawardena R, Sooriyaarachchi P, Chourdakis M. Enhancing immunity in viral infections, with special emphasis on COVID-19 : A review. Diabetes Metab Syndr Clin Res Rev 2020; 14: 367–382
19. FAO (2020) Maintaining a healthy diet during the COVID-19 pandemic. Rome
20. Schmulson M, Dávalos MF, Berumen J. Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19. Rev Gastroenterol Mex 2020; 85.3 :282-287
21. Lee HK, Hwang IH, Kim SY, Pyo SY. The effect of probiotics on prevention of the common cold: A meta-analysis of randomized controlled trial studies. Korean J Fam Med 2013; 34:2–10.
22. Berggren A, Ahrén I, Larsson N, Önning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 2011; 50 (3): 203–210
23. Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009; 27(41):5677–5684
24. Akatsu H, Iwabuchi N, Xiao JZ, Matsuyama Z, Kurihara R, Okuda K, Yamamoto T, Maruyama M. Clinical effects of probiotic bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. J Parenter Enter Nutr 2013; 37(5): 631–640.
25. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: Probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9 (15): 1–11.
26. Tong JL, Ran ZH, Shen J, Zhang CX XS. Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25(2): 155–168
27. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369:1614–1620.
28. Hawrelak JA, Whitten DL MS. Is Lactobacillus Rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: A systematic review. Digestion 2005; 72(1): 51–56
29. Sazawal S, Hiremath G, Dhingra U, Malik P DS. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6(6):374–382
30. Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res 2020; 285:198018

Details

Primary Language

English

Subjects

Nutrition and Dietetics

Journal Section

Research Article

Authors

Dilşat Baş ^*
0000-0002-2991-7774
Türkiye

Şengül Sangu Talak
0000-0003-3455-1807
Türkiye

Nur Ecem Baydı Ozman
0000-0001-6052-0057
Türkiye

Deniz Nadide Kitay
0000-0002-3098-734X
Türkiye

Hazal Çatırtan
0000-0003-2829-7793
Türkiye

Ayşe Sena Binöz
0000-0003-2069-8920
Türkiye

Nilay Öngen
0000-0002-1035-3913
Türkiye

Efe Onganer
0000-0001-7142-0094
Türkiye

Murat Baş
0000-0002-0494-301X
Türkiye

Early Pub Date

May 31, 2023

Publication Date

July 10, 2023

Submission Date

March 21, 2022

Acceptance Date

March 26, 2023

Published in Issue

Year 2023 Volume: 14 Number: 3

DOI

https://doi.org/10.31067/acusaglik.1086369

IZ

https://izlik.org/JA99EY35EK

Cite

RIS / Bibtex

EndNote

Baş D, Sangu Talak Ş, Baydı Ozman NE, Kitay DN, Çatırtan H, Binöz AS, Öngen N, Onganer E, Baş M (July 1, 2023) Evaluation of Gastrointestinal Life Quality and Food Consumption and Choices in Recovered Covid-19 Patients. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 3 438–446.

Öz

Evaluation of Gastrointestinal Life Quality and Food Consumption and Choices in Recovered Covid-19 Patients

Abstract

Keywords

References

Details

Primary Language

Subjects

Journal Section

Authors

Early Pub Date

Publication Date

Submission Date

Acceptance Date

Published in Issue

DOI

IZ

Cite